BioCyto’s scientific focus is centred on the development of advanced therapeutic and delivery strategies for disorders affecting the central nervous system.
Our research integrates computational biology, translational nanomedicine, and targeted delivery engineering to address key challenges in CNS therapeutic development, including delivery efficiency, biological complexity, and translational feasibility.
Explore BioCyto’s technical white papers, external thought-leadership perspectives, and translational research insights focused on AI-enabled therapeutics, nanomedicine, and CNS delivery innovation.
Featured Publication
Mitochondrial Complex I Controls Blood Brain Barrier Permeability
Davis GM, Juerre E, Hayes JM, Davey GP
Published 2023
Featured White Paper
Engineering Lipid Nanoparticle Architectures for Delivery to CNS-Resident Cells
BioCyto’s white paper presents an experimentally informed comparative assessment of nanoparticle delivery architectures for CNS applications, examining how physicochemical design, biological environment, and cellular interaction influence translational delivery performance across CNS-relevant systems.
Thought Leaders
This expert perspective explores emerging scientific and translational trends shaping the future of CNS therapeutic engineering, including AI-assisted formulation optimisation, biologically informed nanoparticle design, blood-brain barrier transport complexity, and adaptive delivery architectures. Drawing upon developments across computational therapeutics, systems biology, and translational nanomedicine, the document examines how integrated platform approaches may influence the next generation of CNS-targeted therapeutic systems.
